Click on the question to see the answer:
- What is Nasaleze?
- Who is it for?
- Why a powder?
- Can Nasaleze prevent hay fever?
- How was Nasaleze discovered?
Nasaleze is a revolutionary new approach to allergy management, and is clinically proven to provide relief from hayfever and allergy symptoms. Nasaleze does not contain antihistamines or steroids, making it suitable for everyone including children (from 18 months) and pregnant or breastfeeding women. Nasaleze has no known side effects or negative interactions with other medication.
Hayfever occurs as a result of airborne allergens entering the nose, causing the body to release histamine as a defence mechanism.
Nasaleze works by creating a barrier between the airborne allergens and the lining of the nose. Upon puffing the Nasaleze powder into the nose it reacts with the moisture to form a gel, this gel lines the sensitive nasal membrane giving protection against allergens. The risk of allergens coming into contact with the nasal membrane is reduced, therefore the likelihood of the body to release histamine as a response is minimised and the allergic reaction avoided.
Many sufferers are looking for something new. Even ‘non-drowsy’ antihistamines can have a hangover effect and long term use of steroids is not desirable.
Some sufferers will already be taking medication for other reasons and will not want to combine drugs. Others may be pregnant or breastfeeding and parents of school-age children will want genuinely non-sedating treatment.
Some people find their hayfever so severe that not one treatment type brings adequate relief. For this group of people a combination therapy including Nasaleze Allergy, a daily anti-histamine and eye drops will help them survive the summer as comfortably as possible.
The unique grade of cellulose powder used in Nasaleze forms an excellent barrier to allergens which has been clinically proven to remain impermeable for several hours.
Being a powder the barrier created remains in situ to keep you protected.
Nasaleze powder dry (taken from 100x magnification)
Nasaleze powder after exposure to damp surface (taken from 100x magnification)
Nasaleze should be taken as soon as symptoms appear. The recommended dosage is three times a day but it can be taken as often as required.
Nasaleze can also be taken as a preventative measure before entering an environment where airborne allergens are likely to be present like going into the garden, dusting or if the pollen count is high.
The Nasaleze story all began one day in 1990...
Mike James was working in a factory making cosmetic facemasks for a well-known British healthcare product retailer using a number of ingredients. Mike noticed that despite there usually being clouds of white powder in the air nobody ever sneezed.
At the same time his teenage son was suffering terribly from allergies, sneezing almost constantly. Mike’s wife asked he do something about their son’s condition, under pressure Mike’s mind was cast back to the clouds of white powder in the factory. The following day he brought home some of this (cellulose) powder and suggested his sneezing son should ‘sniff’ some of the powder off the back of his hand.
The effect was like switching off a light
The sneezing stopped in a matter of seconds and all the other symptoms subsided over the next few minutes. Mike was astonished by the effect and realized he had discovered something.
Mike immediately set about researching and developing his idea, including creating the unique and patented special delivery system. After the initial research proved encouraging Mike was ready to bring his invention to market.
However, the Medicines Control Agency (as it was known at the time) had other ideas, claiming that Mike was illegally producing a pharmaceutical product and that he should stop immediately. Undeterred, Mike went about proving that his product was natural a nd not a drug. In order to get the Medicines Control Agency to approve Mike invoked the help of a political friend, Sir Teddy Taylor MP.
In the UK there is a weekly opportunity for a Member of Parliament to ask the Prime Minister a question in the House of Commons, known as Prime Minister’s Question Time. Upon Mike’s request, Sir Teddy Taylor asked the Prime Minister why Mr. James was being prevented from manufacturing and selling his natural allergy product. After this the Medicines Control Agency were forced to look into the issue in greater detail and came to the conclusion that Nasaleze was in fact a low risk product, not a d rug and that it should be registered as a Class 1 Medical Device under EU Directive 93/42/EEC.
From humble beginnings
Nasaleze is now distributed in over 50 countries worldwide and is gaining respect from the Medical Community after successive and successful clinical studies.